中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

20 records (took 0.021 seconds)

    HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS
    3.
    发明申请
    HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS 审中-公开
    HEMANGIO COLONY成形细胞和非恒定HEMANGIO细胞

    公开(公告)号：WO2009137624A2

    公开(公告)日：2009-11-12

    申请号：PCT/US2009/043043

    申请日：2009-05-06

    Applicant: ADVANCED CELL TECHNOLOGY, INC. ,  LANZA, Robert ,  LU, Shi-Jiang

    Inventor： LANZA, Robert ,  LU, Shi-Jiang

    IPC: C12N5/08

    CPC classification number: C12N5/0647 ,  A61K35/12 ,  A61K35/28 ,  A61K35/44 ,  A61K38/13 ,  A61K45/06 ,  A61K2035/124 ,  A61N5/10 ,  C12N2500/90 ,  C12N2501/115 ,  C12N2501/125 ,  C12N2501/14 ,  C12N2501/145 ,  C12N2501/155 ,  C12N2501/165 ,  C12N2501/26 ,  C12N2506/02 ,  C12N2506/45

    Abstract: Methods of generating and expanding human hemangio-colony forming cells and non-engrafting hemangio cells in vitro and methods of expanding and using such cells are disclosed. The methods permit the production of large numbers of hemangio-colony forming cells, non-engrafting hemangio cells as well as derivative cells, such as hematopoietic and endothelial cells. The cells obtained by the methods disclosed may be used for a variety of research, clinical, and therapeutic applications. Human non-engrafting hemangio cells are a novel progenitor cell population that is related to but distinct from the hemangioblast and human hemangio-colony forming cells. The invention also provides compositions, preparations, and solutions comprising hemangio-colony forming cells, non-engrafting hemangio cells or cells differentiated therefrom. The compositions, preparations, and solutions include cryopreserved preparations and substantially purified preparations, as well as mixed compositions formulated in combination with related hemangioblast progenitor cell types that can engraft into the bone marrow.

    Abstract translation: 公开了在体外产生和扩大人血管瘤集落形成细胞和非移植血管瘤细胞的方法以及扩增和使用这些细胞的方法。 该方法允许生产大量的血管瘤集落形成细胞，非移植血管瘤细胞以及衍生细胞，如造血细胞和内皮细胞。 通过所公开的方法获得的细胞可用于各种研究，临床和治疗应用。 人类非移植血管瘤细胞是与成血管细胞和人血管瘤集落形成细胞相关但不同的新型祖细胞群。 本发明还提供包含血管瘤集落形成细胞，非移植血管瘤细胞或与其分化的细胞的组合物，制剂和溶液。 组合物，制剂和溶液包括冷冻保存的制剂和基本纯化的制剂，以及与可以移入骨髓的相关成血管细胞祖细胞类型组合配制的混合组合物。

    METHODS AND APPARATUS TO COLLECT BROADBAND MARKET DATA
    8.
    发明申请
    METHODS AND APPARATUS TO COLLECT BROADBAND MARKET DATA 审中-公开
    收集宽带市场数据的方法和设备

    公开(公告)号：WO2010088369A2

    公开(公告)日：2010-08-05

    申请号：PCT/US2010/022384

    申请日：2010-01-28

    Applicant: THE NIELSEN COMPANY (US), LLC ,  LU, Shi ,  FRY, Ranney ,  BACCELLI, Jerome

    Inventor： LU, Shi ,  FRY, Ranney ,  BACCELLI, Jerome

    IPC: G06Q10/00 ,  G06F17/30 ,  G06Q50/00

    CPC classification number: G06Q30/02 ,  G06Q30/0203 ,  H04L67/16

    Abstract: Example methods and apparatus to collect broadband market data are disclosed. A disclosed example method includes selecting a panelist household, the panelist household subscribing to at least one broadband service delivered via a modem, and identifying an Internet protocol (IP) address assigned to the modem by an Internet service provider (ISP). The example method also includes retrieving a range of IP addresses associated with the ISP, selecting a random subset of IP addresses from the range of IP addresses, and testing each of the IP addresses from the random subset to determine an activity status of each IP address.

    Abstract translation: 公开了用于收集宽带市场数据的示例性方法和设备。 所公开的示例方法包括选择小组成员家庭，小组成员家庭订阅经由调制解调器递送的至少一个宽带服务，并且识别由因特网服务提供商（ISP）分配给调制解调器的因特网协议（IP）地址。 示例方法还包括检索与ISP相关联的IP地址范围，从该IP地址范围中选择IP地址的随机子集，并且测试来自随机子集的每个IP地址以确定每个IP地址的活动状态

    HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS
    9.
    发明申请
    HEMANGIO COLONY FORMING CELLS AND NON-ENGRAFTING HEMANGIO CELLS 审中-公开
    HEMANGIO COLONY成形细胞和非恒定HEMANGIO细胞

    公开(公告)号：WO2009137624A3

    公开(公告)日：2010-01-07

    申请号：PCT/US2009043043

    申请日：2009-05-06

    Applicant: ADVANCED CELL TECH INC ,  LANZA ROBERT ,  LU SHI-JIANG

    Inventor： LANZA ROBERT ,  LU SHI-JIANG

    IPC: C12N5/0789

    CPC classification number: C12N5/0647 ,  A61K35/12 ,  A61K35/28 ,  A61K35/44 ,  A61K38/13 ,  A61K45/06 ,  A61K2035/124 ,  A61N5/10 ,  C12N2500/90 ,  C12N2501/115 ,  C12N2501/125 ,  C12N2501/14 ,  C12N2501/145 ,  C12N2501/155 ,  C12N2501/165 ,  C12N2501/26 ,  C12N2506/02 ,  C12N2506/45

    Abstract: Methods of generating and expanding human hemangio-colony forming cells and non-engrafting hemangio cells in vitro and methods of expanding and using such cells are disclosed. The methods permit the production of large numbers of hemangio-colony forming cells, non-engrafting hemangio cells as well as derivative cells, such as hematopoietic and endothelial cells. The cells obtained by the methods disclosed may be used for a variety of research, clinical, and therapeutic applications. Human non-engrafting hemangio cells are a novel progenitor cell population that is related to but distinct from the hemangioblast and human hemangio-colony forming cells. The invention also provides compositions, preparations, and solutions comprising hemangio-colony forming cells, non-engrafting hemangio cells or cells differentiated therefrom. The compositions, preparations, and solutions include cryopreserved preparations and substantially purified preparations, as well as mixed compositions formulated in combination with related hemangioblast progenitor cell types that can engraft into the bone marrow.

    Abstract translation: 公开了在体外产生和扩大人血管瘤集落形成细胞和非移植血管瘤细胞的方法以及扩增和使用这些细胞的方法。 该方法允许生产大量的血管瘤集落形成细胞，非移植血管瘤细胞以及衍生细胞，如造血细胞和内皮细胞。 通过所公开的方法获得的细胞可用于各种研究，临床和治疗应用。 人类非移植血管瘤细胞是与成血管细胞和人血管瘤集落形成细胞相关但不同的新型祖细胞群。 本发明还提供包含血管瘤集落形成细胞，非移植血管瘤细胞或与其分化的细胞的组合物，制剂和溶液。 组合物，制剂和溶液包括冷冻保存的制剂和基本纯化的制剂，以及与可以移入骨髓的相关成血管细胞祖细胞类型组合配制的混合组合物。

Patent Agency Ranking